J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.
New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
UC San Diego bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells.
In Fall 2019, the Center for the Future of Surgery at UC San Diego School of Medicine expanded to address the newest surgical trends, especially those benefiting the brain and the nervous system.
Researchers at the San Diego Supercomputer Center at UC San Diego have launched an open-source software called SeedMeLab, which provides a host of features for researchers across all disciplines to manage and disseminate their data.
UC San Diego Health has enrolled its first patient to evaluate a hand-held technology to fragment kidney stones. The clinical trial will assess the safety and effectiveness of breaking up kidney stones using acoustic energy.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
